Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,496 | -12,052 | -6,604 | -44,582 | -42,226 |
| Depreciation Amortization | 164 | 112 | 56 | 292 | 223 |
| Other Working Capital | -3,739 | -3,562 | -3,756 | -1,726 | -1,662 |
| Other Operating Activity | 1,296 | 1,003 | 921 | -1,568 | 6,996 |
| Operating Cash Flow | $-18,774 | $-14,499 | $-9,383 | $-47,583 | $-36,670 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -104 | -43 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-104 | $-43 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 8,040 | 2,251 | N/A | 61,411 | 61,411 |
| Financing Cash Flow | $8,040 | $2,251 | $0 | $61,411 | $61,411 |
| Beginning Cash Position | 23,289 | 23,289 | 23,289 | 9,565 | 9,565 |
| End Cash Position | 12,554 | 11,041 | 13,905 | 23,289 | 34,263 |
| Net Cash Flow | $-10,734 | $-12,248 | $-9,383 | $13,724 | $24,698 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,774 | -14,499 | -9,383 | -47,583 | -36,670 |
| Capital Expenditure | N/A | N/A | N/A | -104 | -43 |
| Free Cash Flow | -18,774 | -14,499 | -9,383 | -47,687 | -36,712 |